Home Cart 0 Sign in  
X

[ CAS No. 149-91-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 149-91-7
Chemical Structure| 149-91-7
Chemical Structure| 149-91-7
Structure of 149-91-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 149-91-7 ]

Related Doc. of [ 149-91-7 ]

Alternatived Products of [ 149-91-7 ]

Product Details of [ 149-91-7 ]

CAS No. :149-91-7 MDL No. :MFCD00002510
Formula : C7H6O5 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 170.12 Pubchem ID :-
Synonyms :
3,4,5-Trihydroxybenzoic acid;NSC 20103;HSDB 2117;NSC 674319
Chemical Name :3,4,5-Trihydroxybenzoic acid

Calculated chemistry of [ 149-91-7 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 5.0
Num. H-bond donors : 4.0
Molar Refractivity : 39.47
TPSA : 97.99 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.84 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.21
Log Po/w (XLOGP3) : 0.7
Log Po/w (WLOGP) : 0.5
Log Po/w (MLOGP) : -0.16
Log Po/w (SILICOS-IT) : -0.2
Consensus Log Po/w : 0.21

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.64
Solubility : 3.9 mg/ml ; 0.0229 mol/l
Class : Very soluble
Log S (Ali) : -2.34
Solubility : 0.786 mg/ml ; 0.00462 mol/l
Class : Soluble
Log S (SILICOS-IT) : -0.04
Solubility : 155.0 mg/ml ; 0.91 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 1.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.22

Safety of [ 149-91-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 149-91-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 149-91-7 ]
  • Downstream synthetic route of [ 149-91-7 ]

[ 149-91-7 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 71-23-8 ]
  • [ 149-91-7 ]
  • [ 121-79-9 ]
YieldReaction ConditionsOperation in experiment
98% at 100℃; for 5 h; 100 g of gallic acid and 200 g of n-propanol were weighed into a reactor,20 g of the brominated modified sulfonic acid resin obtained in Reference Example 2 was added,Electric stirring,Heating to 100 DEG C to react for 5 h, filtering to obtain the filtrate, and recovering brominated modified sulfonic acid resin;the filtrate obtained in step (1) is distilled off excess alcohol to obtain the crude product, then recrystallization, dewatering and drying are carried out by deionized water to obtain n-propyl gallate,The yield was 98percent and the product purity was 99.9percent.
66%
Stage #1: With diisopropyl-carbodiimide In tetrahydrofuran at 0℃; for 1 h;
Stage #2: With dmap In tetrahydrofuran at 0℃; for 6 h;
General procedure: To the solution containing gallic acid (250 mg, 1.47 mmol) in THF solvent at 0° C is added alcohol (2.94 mmol) and the DIC (0.34 mL, 2.205 mmol) as an activator. The reaction mixture was stirred for 1 h at 0° C, then added DMAP catalyst(18 mg, 0.147 mmol), and stirred again for the next 6 h at 0° C, then allowed to reach room temperature.The reaction was terminated when the TLC analysis showed no spot of the remaining gallic acid. After the reaction is complete, the reaction mixture is diluted with ether, filtered, evaporated,and purified by column silica gel chromatography. Pure compounds were analyzed by Thin Layer Chromatography (TLC), Nuclear Magnetic Resonance Spectrometer (NMR), and High Resolution Mass Spectrometer (HRMS)
2.40 g at 50 - 70℃; for 5 h; Molecular sieve Weighed gallic acid (2.0g) and n-propanol (40mL) were mixed, stirred, heated to 50 ,Product A (100 mg) was added and heating was continued to 70 ° C for 5 hours. The product A was removed by filtration,The filtrate was concentrated under reduced pressure to give propyl gallate (2.40 g, 96.2percent conversion, HPLC purity of about 98.5percent) The propyl gallate obtained in Example 5 or 6 was dissolved in hot ethanol (60 ° C) to be recrystallized once to obtain whiteCrystals (HPLC purity 99.95percent).
Reference: [1] Patent: CN105294433, 2016, A, . Location in patent: Paragraph 0028
[2] Asian Journal of Chemistry, 2015, vol. 27, # 4, p. 1351 - 1354
[3] Journal of Molecular Catalysis B: Enzymatic, 2010, vol. 67, # 3-4, p. 242 - 250
[4] Arzneimittel-Forschung/Drug Research, 2005, vol. 55, # 1, p. 66 - 75
[5] Oriental Journal of Chemistry, 2018, vol. 34, # 2, p. 655 - 662
[6] Journal of Chemical Thermodynamics, 1996, vol. 28, # 2, p. 171 - 185
[7] Patent: US2616042, 1951, ,
[8] Patent: US2616042, 1951, ,
[9] Patent: US2616042, 1951, ,
[10] Archiv der Pharmazie (Weinheim, Germany), 1931, vol. 269, p. 545,560
[11] Journal of the Chemical Society, 1927, p. 2648
[12] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 3, p. 347 - 350
[13] Planta Medica, 2002, vol. 68, # 8, p. 690 - 693
[14] Natural Product Research, 2010, vol. 24, # 18, p. 1758 - 1765
[15] Journal of Agricultural and Food Chemistry, 2010, vol. 58, # 9, p. 5355 - 5362
[16] Current Medicinal Chemistry, 2012, vol. 19, # 26, p. 4534 - 4540,7
[17] Preparative Biochemistry and Biotechnology, 2013, vol. 43, # 5, p. 445 - 455
[18] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 7, p. 1812 - 1814
[19] Patent: CN106117052, 2016, A, . Location in patent: Paragraph 0009
[20] Patent: CN107488111, 2017, A, . Location in patent: Paragraph 0042; 0043; 0045; 0053
  • 2
  • [ 149-91-7 ]
  • [ 71-36-3 ]
  • [ 121-79-9 ]
YieldReaction ConditionsOperation in experiment
75% With sulfuric acid In propan-1-ol; 2-methyl-propan-1-ol; water EXAMPLE 1
Preparation of N-propyl gallate
A mixture of 500 g of tara (theoretical gallic acid content about 1.5 moles), 2,000 g (33.3 moles) of n-propanol and 50 g of anhydrous sulfuric acid was refluxed at 100° C. for 25 hours, the water of reaction being removed continuously in the form of a propanol/water azeotrope.
When water was no longer eliminated, the mixture was neutralized with dilute sodium hydroxide solution and freed from excess propanol by distillation.
The residue was taken up in a mixture of 900 ml of isobutanol and 600 ml of n-butanol, and this solution was then washed with a total of 6 l of water.
The organic phase was evaporated down, after which 400 g of a crude n-propyl gallate having a purity of 60percent (according to HPLC analysis) were obtained in the form of an oil.
The yield was 75percent, based on the gallic acid content of the tara used, and converted to pure ester.
Recrystallization from water gave the ester in a yield of 60percent and with a purity of 95percent.
Reference: [1] Patent: US4613683, 1986, A,
  • 3
  • [ 71-23-8 ]
  • [ 99-24-1 ]
  • [ 121-79-9 ]
  • [ 149-91-7 ]
Reference: [1] Food Chemistry, 2011, vol. 128, # 1, p. 214 - 217
  • 4
  • [ 71-23-8 ]
  • [ 18483-17-5 ]
  • [ 121-79-9 ]
  • [ 149-91-7 ]
Reference: [1] Food Chemistry, 2011, vol. 128, # 1, p. 214 - 217
  • 5
  • [ 1403239-94-0 ]
  • [ 2280-44-6 ]
  • [ 149-91-7 ]
  • [ 32492-74-3 ]
Reference: [1] Journal of Natural Products, 2012, vol. 75, # 10, p. 1798 - 1802
  • 6
  • [ 64-17-5 ]
  • [ 149-91-7 ]
  • [ 831-61-8 ]
YieldReaction ConditionsOperation in experiment
98% at 80℃; for 5 h; 100 g of gallic acid and 150 g of ethanol were weighed into a reactor, 35 g of the brominated modified sulfonic acid resin obtained in Referential Example 2 was weighed, heated to 80 ° C for 5 h, filtered to obtain a filtrate, and bromine Modified sulfonic acid resin;the filtrate obtained in step (1) is distilled off excess alcohol to obtain crude product, and then recrystallization, dewatering and drying are carried out by deionized water to obtain ethyl gallate in 98percent yield and purity of 99.9percent .
92% at 70℃; for 24 h; To a 50 mL round bottom flask, the gallic acid (2.0 g, 11.8 mmol), ethanol (30 mL, 1.94 mol) and 10percent of concentrated sulfuric acid (0.2 mL) were vigorously stirred at 70°C in reflux apparatus. The reaction was monitored by TLC until end of reaction (24 h). The product was extracted using 20 mL of saturated solution of sodium bicarbonate (NaHCO3), 20 mL of distilled water and finally extracted for three times with 20 mL of ethyl acetate. The collected organic phase was evaporated and Na2SO4 anhydrous was added. After extraction ethyl gallate G was obtained already purified (92percent) and it was characterized by IR, GC-MS and NMR analyses.
70% at 100℃; for 0.833333 h; Microwave irradiation General procedure: A microwave vial was loaded with gallic acid 1 (0.3mmol, 50mg), the corresponding alcohol (0.9mmol), and concentrated H2SO4 (0.07mL). The reaction vessel was sealed and irradiated in a microwave reactor at 100°C for 50min. After cooling, volatiles were evaporated to dryness and the residue was dissolved in ethyl acetate (30mL) and washed successively with saturated solutions of NaHCO3 (3×20mL) and NaCl (1×20mL). The organic layer was dried over anhydrous Na2SO4, filtered and concentrated under vacuum. The residue was then purified by column chromatography using hexane/EtOAc, (3:7) as the eluent. Melting points and characterization of compounds 2–7 were consistent with those found in the literature [25d]. In our case, the following yields were obtained: 2 (70percent), 3 (97percent), 4 (83percent), 5 (98percent), 6 (96percent), 7 (82percent).
69%
Stage #1: With diisopropyl-carbodiimide In tetrahydrofuran at 0℃; for 1 h;
Stage #2: With dmap In tetrahydrofuran at 0℃; for 6 h;
General procedure: To the solution containing gallic acid (250 mg, 1.47 mmol) in THF solvent at 0° C is added alcohol (2.94 mmol) and the DIC (0.34 mL, 2.205 mmol) as an activator. The reaction mixture was stirred for 1 h at 0° C, then added DMAP catalyst(18 mg, 0.147 mmol), and stirred again for the next 6 h at 0° C, then allowed to reach room temperature.The reaction was terminated when the TLC analysis showed no spot of the remaining gallic acid. After the reaction is complete, the reaction mixture is diluted with ether, filtered, evaporated,and purified by column silica gel chromatography. Pure compounds were analyzed by Thin Layer Chromatography (TLC), Nuclear Magnetic Resonance Spectrometer (NMR), and High Resolution Mass Spectrometer (HRMS)
51.5% Reflux General procedure: In 50 ml_ of the alcohol of interest, 3,4,5-trihydroxybenzoic acid (1 ) (1 .5 g, 8.85 mmol) was dissolved, followed by addition of 10 drops of sulfuric acid. The solution was refluxed overnight. Afterwards, the solution was allowed to cool to room temperature. The residual alcohol was evaporated, yielding the gallic acid ester derivatives 22, 23, 24 as a solid compound.
47.2% for 40 h; Heating / reflux In a flask was charged 15.1 g of 3,4,5-trihydroxybenzoic acid (1), and 160 ml of ethanol and 5 ml of sulfuric acid were added thereto in the order cited and heating with stirring was performed for 40 hours under reflux. Thereafter, the solvent was distilled off, the residue was extracted with ether and the organic layer was dried over magnesium sulfate. After the magnesium sulfate was filtered off, and the organic solvent was evaporated to afford a white solid (2) (yield of the reaction: 17.6 g, percent yield:47.2percent).

Reference: [1] Patent: CN105294433, 2016, A, . Location in patent: Paragraph 0026
[2] Asian Journal of Chemistry, 2015, vol. 27, # 4, p. 1351 - 1354
[3] New Journal of Chemistry, 2018, vol. 42, # 20, p. 16999 - 17008
[4] ChemPhysChem, 2016, p. 2225 - 2237
[5] Tetrahedron, 2009, vol. 65, # 40, p. 8354 - 8361
[6] Tetrahedron Letters, 2017, vol. 58, # 9, p. 825 - 828
[7] Angewandte Chemie - International Edition, 2012, vol. 51, # 49, p. 12246 - 12249[8] Angew. Chem., 2012, vol. 124, # 49, p. 12412 - 12415,4
[9] Arzneimittel-Forschung/Drug Research, 2005, vol. 55, # 1, p. 66 - 75
[10] Journal of Organic Chemistry, 2013, vol. 78, # 2, p. 527 - 544
[11] European Journal of Medicinal Chemistry, 2015, vol. 92, p. 656 - 671
[12] New Journal of Chemistry, 2018, vol. 42, # 7, p. 5382 - 5394
[13] Oriental Journal of Chemistry, 2018, vol. 34, # 2, p. 655 - 662
[14] Patent: WO2018/96088, 2018, A1, . Location in patent: Page/Page column 33; 40
[15] Patent: EP1389605, 2004, A1, . Location in patent: Page 4
[16] Justus Liebigs Annalen der Chemie, 1872, vol. 163, p. 218[17] Chemische Berichte, 1879, vol. 12, p. 1533
[18] Bulletin de la Societe Chimique de France, 1864, vol. <2> 2, p. 94[19] Jahresbericht ueber die Fortschritte der Chemie und Verwandter Theile Anderer Wissenschaften, 1864, p. 404
[20] Chemische Berichte, 1905, vol. 38, p. 3348
[21] Patent: US2615042, 1951, ,
[22] Chemische Berichte, 1905, vol. 38, p. 3348
[23] Tetrahedron, 1997, vol. 53, # 6, p. 2163 - 2176
[24] Planta Medica, 2002, vol. 68, # 8, p. 690 - 693
[25] Chemical Communications, 2003, # 18, p. 2306 - 2307
[26] Tetrahedron Letters, 2009, vol. 50, # 49, p. 6901 - 6905
[27] Natural Product Research, 2010, vol. 24, # 18, p. 1758 - 1765
[28] Molecular Crystals and Liquid Crystals, 2010, vol. 518, p. 160 - 167
[29] Current Medicinal Chemistry, 2012, vol. 19, # 26, p. 4534 - 4540,7
[30] European Journal of Medicinal Chemistry, 2013, vol. 62, p. 289 - 296
[31] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 7, p. 1812 - 1814
[32] Dyes and Pigments, 2015, vol. 119, p. 108 - 115
[33] Bulletin of the Korean Chemical Society, 2015, vol. 36, # 11, p. 2682 - 2687
[34] Carbohydrate Polymers, 2016, vol. 140, p. 171 - 180
[35] Bulletin of the Korean Chemical Society, 2015, vol. 36, # 11, p. 2740 - 2745
[36] Chemistry - A European Journal, 2018,
  • 7
  • [ 64-67-5 ]
  • [ 149-91-7 ]
  • [ 831-61-8 ]
Reference: [1] Synthetic Communications, 2008, vol. 38, # 6, p. 928 - 936
  • 8
  • [ 111-87-5 ]
  • [ 149-91-7 ]
  • [ 1034-01-1 ]
YieldReaction ConditionsOperation in experiment
96% at 100℃; for 0.833333 h; Microwave irradiation General procedure: A microwave vial was loaded with gallic acid 1 (0.3mmol, 50mg), the corresponding alcohol (0.9mmol), and concentrated H2SO4 (0.07mL). The reaction vessel was sealed and irradiated in a microwave reactor at 100°C for 50min. After cooling, volatiles were evaporated to dryness and the residue was dissolved in ethyl acetate (30mL) and washed successively with saturated solutions of NaHCO3 (3×20mL) and NaCl (1×20mL). The organic layer was dried over anhydrous Na2SO4, filtered and concentrated under vacuum. The residue was then purified by column chromatography using hexane/EtOAc, (3:7) as the eluent. Melting points and characterization of compounds 2–7 were consistent with those found in the literature [25d]. In our case, the following yields were obtained: 2 (70percent), 3 (97percent), 4 (83percent), 5 (98percent), 6 (96percent), 7 (82percent).
51%
Stage #1: With diisopropyl-carbodiimide In tetrahydrofuran at 0℃; for 1 h;
Stage #2: With dmap In tetrahydrofuran at 0℃; for 6 h;
General procedure: To the solution containing gallic acid (250 mg, 1.47 mmol) in THF solvent at 0° C is added alcohol (2.94 mmol) and the DIC (0.34 mL, 2.205 mmol) as an activator. The reaction mixture was stirred for 1 h at 0° C, then added DMAP catalyst(18 mg, 0.147 mmol), and stirred again for the next 6 h at 0° C, then allowed to reach room temperature.The reaction was terminated when the TLC analysis showed no spot of the remaining gallic acid. After the reaction is complete, the reaction mixture is diluted with ether, filtered, evaporated,and purified by column silica gel chromatography. Pure compounds were analyzed by Thin Layer Chromatography (TLC), Nuclear Magnetic Resonance Spectrometer (NMR), and High Resolution Mass Spectrometer (HRMS)
Reference: [1] European Journal of Medicinal Chemistry, 2015, vol. 92, p. 656 - 671
[2] Journal of Agricultural and Food Chemistry, 2002, vol. 50, # 14, p. 3992 - 3998
[3] Journal of Agricultural and Food Chemistry, 2002, vol. 50, # 23, p. 6692 - 6696
[4] Journal of Agricultural and Food Chemistry, 2000, vol. 48, # 4, p. 1393 - 1399
[5] Arzneimittel-Forschung/Drug Research, 2005, vol. 55, # 1, p. 66 - 75
[6] Oriental Journal of Chemistry, 2018, vol. 34, # 2, p. 655 - 662
[7] Angewandte Chemie - International Edition, 2012, vol. 51, # 49, p. 12246 - 12249[8] Angew. Chem., 2012, vol. 124, # 49, p. 12412 - 12415,4
[9] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 1, p. 51 - 55
[10] DRP/DRBP Org.Chem.,
[11] Patent: US2623897, 1949, ,
[12] Journal of the American Chemical Society, 1947, vol. 69, p. 2003
[13] Recueil des Travaux Chimiques des Pays-Bas, 1951, vol. 70, p. 277,281
[14] DRP/DRBP Org.Chem.,
[15] Patent: US2623897, 1949, ,
[16] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 3, p. 347 - 350
[17] Current Medicinal Chemistry, 2012, vol. 19, # 26, p. 4534 - 4540,7
[18] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 7, p. 1812 - 1814
[19] Journal of Enzyme Inhibition and Medicinal Chemistry, 2015, vol. 30, # 2, p. 299 - 307
  • 9
  • [ 6906-38-3 ]
  • [ 149-91-7 ]
  • [ 487-70-7 ]
Reference: [1] Journal of Agricultural and Food Chemistry, 2009, vol. 57, # 12, p. 5271 - 5278
  • 10
  • [ 149-91-7 ]
  • [ 21852-50-6 ]
Reference: [1] Patent: CN108503561, 2018, A,
[2] Journal of Enzyme Inhibition and Medicinal Chemistry, 2018, vol. 33, # 1, p. 1554 - 1564
[3] Patent: CN108727222, 2018, A,
  • 11
  • [ 99-50-3 ]
  • [ 89-86-1 ]
  • [ 149-91-7 ]
  • [ 99-10-5 ]
  • [ 303-38-8 ]
  • [ 490-79-9 ]
  • [ 99-06-9 ]
  • [ 69-72-7 ]
  • [ 74-88-4 ]
  • [ 99-96-7 ]
  • [ 2150-41-6 ]
  • [ 606-45-1 ]
  • [ 5368-81-0 ]
  • [ 121-98-2 ]
  • [ 2150-38-1 ]
  • [ 1916-07-0 ]
  • [ 2150-42-7 ]
  • [ 2150-40-5 ]
  • [ 2150-37-0 ]
Reference: [1] Chemical Communications, 2014, vol. 50, # 14, p. 1694 - 1697
  • 12
  • [ 149-91-7 ]
  • [ 70424-94-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2003, vol. 51, # 9, p. 1085 - 1088
[2] Synthetic Communications, 2002, vol. 32, # 20, p. 3149 - 3158
[3] Organic and Biomolecular Chemistry, 2014, vol. 12, # 1, p. 73 - 85
[4] Tetrahedron Letters, 2016, vol. 57, # 24, p. 2652 - 2654
[5] Heterocycles, 2014, vol. 8, # 2, p. 1371 - 1396
[6] Tetrahedron Letters, 2016, vol. 57, # 49, p. 5469 - 5474
[7] Journal of Medicinal Chemistry, 2018, vol. 61, # 4, p. 1609 - 1621
[8] Monatshefte fur Chemie, 2018, vol. 149, # 7, p. 1293 - 1300
  • 13
  • [ 149-91-7 ]
  • [ 116119-01-8 ]
Reference: [1] Tetrahedron, 2005, vol. 61, # 7, p. 1909 - 1918
[2] Patent: US2013/331390, 2013, A1,
  • 14
  • [ 149-91-7 ]
  • [ 7732-18-5 ]
  • [ 99-26-3 ]
Reference: [1] Patent: CN106565788, 2017, A, . Location in patent: Paragraph 0031
Same Skeleton Products
Historical Records